DDDIX
Price
$22.10
Change
-$0.03 (-0.14%)
Updated
Oct 17 closing price
Net Assets
106.39M
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

DDDIX vs VIMAX

Header iconDDDIX vs VIMAX Comparison
Open Charts DDDIX vs VIMAXBanner chart's image
13D Activist I
Price$22.10
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets106.39M
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
DDDIX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
DDDIX vs. VIMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDIX is a Hold and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. DDDIX (106M). VIMAX pays higher dividends than DDDIX: VIMAX (1.48) vs DDDIX (0.00). DDDIX was incepted earlier than VIMAX: DDDIX (14 years) vs VIMAX (24 years). DDDIX (1.51) is less costly to investors than VIMAX (0.05). DDDIX is a more actively managed with annual turnover of: 104.00 vs. VIMAX (16.00). VIMAX has a lower initial minimum investment than DDDIX: VIMAX (3000) vs DDDIX (1000000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. DDDIX (-1.52). VIMAX return over 5 years is better than : 57.32 vs. DDDIX (1.88).
DDDIXVIMAXDDDIX / VIMAX
Total Expense Ratio1.510.053,020%
Annual Report Gross Expense Ratio1.510.053,020%
Fund Existence14 years24 years-
Gain YTD4.4929.70746%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets106M201B0%
Annual Yield % from dividends0.001.48-
Returns for 1 year-1.527.58-20%
Returns for 3 years3.4649.707%
Returns for 5 years1.8857.323%
Returns for 10 years42.42140.9330%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
ABVC2.92N/A
N/A
ABVC BioPharma
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals